(Q43728397)

26 November 2017

title

Ratio of cathepsin B to stefin A identifies heterogeneity within Gleason histologic scores for human prostate cancer (English)

1 reference

26 November 2017

1 reference

Sinha AA

1

1 reference

26 November 2017

Quast BJ

2

1 reference

26 November 2017

Wilson MJ

3

1 reference

26 November 2017

Fernandes ET

4

1 reference

26 November 2017

Reddy PK

5

1 reference

26 November 2017

Ewing SL

6

1 reference

26 November 2017

Sloane BF

7

1 reference

26 November 2017

Gleason DF

8

1 reference

26 November 2017

publication date

1 September 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

48

1 reference

26 November 2017

issue

4

1 reference

26 November 2017

page(s)

274-284

1 reference

Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer.

26 November 2017

cites work

1 reference

Natural history of progression after PSA elevation following radical prostatectomy

21 January 2018

1 reference

Localization and quantification of mRNA for matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) in human benign and malignant prostatic tissue.

21 January 2018

1 reference

Matrix metalloproteinases: biologic activity and clinical implications

21 January 2018

1 reference

ECM and cell surface proteolysis: regulating cellular ecology

21 January 2018

1 reference

Cathepsin B and its endogenous inhibitors: the role in tumor malignancy

21 January 2018

1 reference

Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients

21 January 2018

1 reference

Emerging roles for cysteine proteases in human biology

21 January 2018

1 reference

Tumor cell membrane cathepsin B.

21 January 2018

1 reference

Localization of cathepsin B in normal and hyperplastic human prostate by immunoperoxidase and protein A-gold techniques

21 January 2018

1 reference

Localization of a biotinylated cathepsin B oligonucleotide probe in human prostate including invasive cells and invasive edges by in situ hybridization

21 January 2018

1 reference

Improved section adhesion for immunocytochemistry using high molecular weight polymers of L-lysine as a slide coating

21 January 2018

1 reference

Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors

21 January 2018

1 reference

Future prospects in prostate cancer

21 January 2018

1 reference

Ability to predict biochemical progression using Gleason score and a computer-generated quantitative nuclear grade derived from cancer cell nuclei

21 January 2018

1 reference

Correlation of pathologic findings with progression after radical retropubic prostatectomy

21 January 2018

1 reference

Morphology of prostate cancer: the effects of multifocality on histological grade, tumor volume and capsule penetration.

21 January 2018

1 reference

Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer

21 January 2018

1 reference

Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis

21 January 2018

1 reference

Immunocytochemical and immunoelectron microscopic demonstration of cathepsin B in human malignant melanoma

21 January 2018

1 reference

Molecular regulation, membrane association and secretion of tumor cathepsin B.

21 January 2018

1 reference

Immunohistochemical localization of cathepsin B in neoplastic human prostate

21 January 2018

1 reference

Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PROS.1107

1 reference

26 November 2017

1 reference